Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 90.49B |
| Enterprise value | 79.30B |
| Trailing P/E | 26.36 |
| Forward P/E | 22.17 |
| PEG ratio (5-yr expected) | 0.50 |
| Price/sales (ttm) | 9.47 |
| Price/book (mrq) | 5.48 |
| Enterprise value/revenue | 8.21 |
| Enterprise value/EBITDA | 17.57 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.42 |
| 52-week change 3 | 12.62% |
| S&P500 52-week change 3 | 16.58% |
| 52-week high 3 | 387.42 |
| 52-week low 3 | 282.21 |
| 50-day moving average 3 | 360.61 |
| 200-day moving average 3 | 340.27 |
Share statistics
| Avg vol (3-month) 3 | 1.22M |
| Avg vol (10-day) 3 | 1.31M |
| Shares outstanding 5 | 257.68M |
| Implied shares outstanding 6 | 257.68M |
| Float 8 | 256.98M |
| % held by insiders 1 | 0.17% |
| % held by institutions 1 | 96.55% |
| Shares short (14 Nov 2023) 4 | 2.51M |
| Short ratio (14 Nov 2023) 4 | 1.79 |
| Short % of float (14 Nov 2023) 4 | 0.97% |
| Short % of shares outstanding (14 Nov 2023) 4 | 0.97% |
| Shares short (prior month 12 Oct 2023) 4 | 2.86M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 2:1 |
| Last split date 3 | 23 Aug 2000 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Sept 2023 |
Profitability
| Profit margin | 35.94% |
| Operating margin (ttm) | 43.93% |
Management effectiveness
| Return on assets (ttm) | 14.34% |
| Return on equity (ttm) | 23.49% |
Income statement
| Revenue (ttm) | 9.65B |
| Revenue per share (ttm) | 37.49 |
| Quarterly revenue growth (yoy) | 6.40% |
| Gross profit (ttm) | 5.32B |
| EBITDA | 4.57B |
| Net income avi to common (ttm) | 3.47B |
| Diluted EPS (ttm) | 13.29 |
| Quarterly earnings growth (yoy) | 11.30% |
Balance sheet
| Total cash (mrq) | 11.93B |
| Total cash per share (mrq) | 46.29 |
| Total debt (mrq) | 744.7M |
| Total debt/equity (mrq) | 4.51% |
| Current ratio (mrq) | 4.08 |
| Book value per share (mrq) | 64.05 |
Cash flow statement
| Operating cash flow (ttm) | 4.38B |
| Levered free cash flow (ttm) | 3.92B |
© 2023 Yahoo. All rights reserved.